New DNA Test Predicts Susceptibility to Opioid Addiction
The U.S. Food and Drug Administration has approved the use of a new DNA test to identify patients at risk of opioid use disorder.
Buprenorphine As an Emergency Treatment for Opioid Overdose
Training and equipping emergency medical personnel to administer buprenorphine is a money saver and a lifesaver.
How Does Delay Discounting Relate to Addiction?
Delay discounting is a measure of how much you have to reward a person to delay gratification. Two studies look at how it impacts addiction.
How the Demonization of Addiction Costs Municipalities Lives and Money
Due to stigma and moral hazard, many communities suffer more overdose deaths, lost income and unreimbursed costs.
More States Allow Pharmacists to Prescribe Buprenorphine for Opioid Use Disorder
States are slowly allowing their pharmacists to prescribe opioid use disorder drugs buprenorphine and naltrexone.
Liraglutide and Semaglutide Show Promise in the Treatment of Opioid Use Disorder and Alcohol Use Disorder
New research indicates that liraglutide, semaglutide, and similar GLP-1 drugs may be effective at reducing cravings for opioids and alcohol.